Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Lumberfeverlongon Dec 19, 2016 9:50am
132 Views
Post# 25618651

RE:RE:RE:News Release

RE:RE:RE:News ReleaseOf course you would have preferred that because that would have likely resulted in the shares falling further and enriching you. The reality is that the company is actually generating marginal free cash. They ended Q3 with $492M in cash and now if you translate the Cinven payment into USD, they had about $500M before making the payment. With the announced expense reduction efforts and assuming that the business has stabilized overall, their ability to generate free cash going forward should improve. Like I have said repeatedly, an imminent C 11 filing is unlikely unless they default. Today shows that the company has no intention on defaulting on their payment obligations to anyone. Good news overall and the market is agreeing in spades.


 
DeathPool wrote: I think they would have been better off to do restructuring before they made any earnout payment, if the cma ends up fining them, the earnout could have been challenged as the period in question in the anti-trust complaint is the period the earnout is calculated.  

What I find curious is they mention the termination of Donntal contract sales team now - and the law suit alleges it was done in May, 2016.  By the looks of their cash on hand it also looks like they really needed the 350 from Goldman - because it is not obvious there was no additional cash from operations.  Gulp.   Long term this is not encouraging.   No forward guidance will keep institutions from buying, imo - and that is what this stock needs for a meaningful move up.  Just my opoinion.  

rad10 wrote: Thanks Trader Ben

I checked Sedar last night - but they waited til this morning.  Overall difficult for the bondholders to gripe about the situation providing all obligations are being met.  Long, slow painful road to recovery over the course of the next few quarters for those prepared to sail the good ship concordia.

Why would any corporation take on a PDT trial for such a rare form of cancer?  I understand an academic building his or her career UHN Toronto Western - but a commercial trial??

GLTA - tis the season of good will so expecting 2 stars for this posting!




<< Previous
Bullboard Posts
Next >>